The California Division of Workers' Compensation announced that its Pharmacy and Therapeutics Committee is meeting virtually Oct. 21.
Committee members are scheduled to discuss topical drug products, GLP-1 drugs and biologics during the meeting. The committee will also discuss proton pump inhibitors and H2 blockers, both of which reduce stomach acid production.
The P&T Committee was created to advise the DWC on evidence-based updates to the prescription drug formulary in the Medical Treatment Utilization Schedule.
The committee meets Oct. 21 from 12:30-2:30 p.m.
Instructions ...
Comments